
Itamar Medical Ltd. Long-Term Debt 2011-2026 | ITMR
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 154 K | - | - | - | 8.17 M | 14.9 M | 14.6 M | 12.7 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.9 M | 154 K | 10.1 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
1.75 M | $ 1.35 | - | $ 21.8 M | ||
|
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
157 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
LENSAR
LNSR
|
2.09 M | $ 5.56 | -8.4 % | $ 64 M | ||
|
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | ||
|
AxoGen
AXGN
|
48.4 M | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
834 M | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Penumbra
PEN
|
20.7 M | $ 334.17 | -0.41 % | $ 13 B | ||
|
Electromed
ELMD
|
1.1 M | $ 24.7 | 0.86 % | $ 209 M | ||
|
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M | ||
|
Insulet Corporation
PODD
|
931 M | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.7 | 3.3 % | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
337 K | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
6.72 M | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | ||
|
Quanterix Corporation
QTRX
|
29.3 M | $ 3.82 | -3.05 % | $ 163 M | ||
|
AdaptHealth Corp.
AHCO
|
1.72 B | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
11.2 M | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
3.48 M | $ 2.4 | -1.64 % | $ 141 M | ||
|
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
2.16 M | $ 3.91 | 4.83 % | $ 146 M | ||
|
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
96.2 M | $ 3.53 | -2.35 % | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
30 M | $ 52.07 | -0.17 % | $ 1.53 B | ||
|
Sintx Technologies
SINT
|
2.84 M | $ 2.57 | 0.78 % | $ 7.13 M | ||
|
Pulmonx Corporation
LUNG
|
37 M | $ 1.31 | -5.76 % | $ 53.3 M | ||
|
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | ||
|
Sensus Healthcare
SRTS
|
209 K | $ 3.96 | -3.65 % | $ 64.7 M | ||
|
InspireMD
NSPR
|
2.22 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
872 K | - | - | $ 2.07 B | ||
|
Second Sight Medical Products
EYES
|
18 M | - | -0.97 % | $ 54.4 M |